On Oct 03, major Wall Street analysts update their ratings for $Humana (HUM.US)$, with price targets ranging from $247 to $402.
Morgan Stanley analyst Erin Wright maintains with a hold rating, and maintains the target price at $374.
J.P. Morgan analyst Lisa Gill maintains with a hold rating, and maintains the target price at $396.
BofA Securities analyst Kevin Fischbeck downgrades to a sell rating, and adjusts the target price from $376 to $247.
BofA Securities analyst Joanna Gajuk initiates coverage with a sell rating, and sets the target price at $247.
Barclays analyst Andrew Mok CFA downgrades to a hold rating, and maintains the target price at $364.
Furthermore, according to the comprehensive report, the opinions of $Humana (HUM.US)$'s main analysts recently are as follows:
Humana is reportedly one metric short of reaching the crucial 4-Star threshold for three of its four impacted plans, which may be significant if their appeal proceeds favorably. Even in the case of an unsuccessful appeal, there are positive indications that the company could rally in the following year. Company leaders are evaluating all options to mitigate the situation, although it is premature to offer precise guidance due to various influencing factors. It is believed that this development casts uncertainty on the company's trajectory towards achieving its 3% margin goal by 2027.
Here are the latest investment ratings and price targets for $Humana (HUM.US)$ from 12 analysts:
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.